http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#Head http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#assertion http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#provenance http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#pubinfo http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#assertion http://purl.obolibrary.org/obo/DOID_5419 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_5419 http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00433 http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association http://www.w3.org/2000/01/rdf-schema#label prochlorperazine maleate tablets are indicated for the control of severe nausea and vomiting prochlorperazine maleate tablets are also indicated for the treatment of schizophrenia prochlorperazine is effective for the short term treatment of generalized non psychotic anxiety however prochlorperazine maleate tablets are not the first drug to be used in therapy for most patients with non psychotic anxiety because certain risks associated with its use are not shared by common alternative treatments e g benzodiazepines when used in the treatment of non psychotic anxiety prochlorperazine maleate tablets should not be administered at doses of more than 2 mg per day or for longer than 12 weeks because the use of prochlorperazine maleate tablets at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible see warnings the effectiveness of prochlorperazine as treatment for non psychotic anxiety was established in 4 week clinical studies of outpatients with generalized anxiety disorder this evidence does not predict that prochlorperazine maleate tablets will be useful in patients with other non psychotic conditions in which anxiety or signs that mimic anxiety are found e g physical illness organic mental conditions agitated depression character pathologies etc prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00433 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#provenance http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#pubinfo http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig http://purl.org/nanopub/x/hasSignature E6hMIG29/6lDx5bO4SyolCLTvAKjvCdP7Ui2i05uN/l5PfTFAfe7PDxMTR5sx6jcApVeylZ68G9bX8CcnTn1XNIFq+DFupr7WSsB7hzUmHarUTKCd0Dl7snETOCv/SU3zIL0hZAeTLmsYGlSGPvoOxXsxFNL58YwkwmkEokqVgM= http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 http://purl.org/dc/terms/created 2021-06-13T13:19:45.930+02:00 http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAB0lKFThgCwDquH5l13OgZupnrIW9gDZ0uEZC6EDghf8 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs